Prognostic significance of serum ca 125 antigen assay in patients with non‐small cell lung cancer

Background. The serum levels of CA 125 tumor‐associated antigen in patients with lung cancer have been previously related to TNM stage, histologic type, and survival rate. In the current study, the prognostic information provided by the CA 125 antigen assay was analyzed.

[1]  R. Bast,et al.  Reactivity of a monoclonal antibody with human ovarian carcinoma. , 1981, The Journal of clinical investigation.

[2]  M. Bronchud.  Haemopoietic growth factors: unravelling the secrets of blood formation. , 1991, European journal of cancer.

[3]  L. de Leij,et al.  Clinical characterization of non-small-cell lung cancer tumors showing neuroendocrine differentiation features. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  T. Saga,et al.  Normal bronchial mucus contains high levels of cancer‐associated antigens, CA125, CA19‐9, and carcinoembryonic antigen , 1990, Cancer.

[5]  C. Angeletti,et al.  The expression of proliferating cell nuclear antigen in paraffin sections of peripheral, node‐negative non‐small cell lung cancer , 1992, Cancer.

[6]  B. Bergman,et al.  Clinical usefulness of serum assays of neuron-specific enolase, carcinoembryonic antigen and CA-50 antigen in the diagnosis of lung cancer. , 1993, European journal of cancer.

[7]  L. Freedman,et al.  The future of prognostic factors in outcome prediction for patients with cancer , 1992, Cancer.

[8]  R. Edwards.  Tribute to Patrick Steptoe: beginnings of laparoscopy. , 1989, Human reproduction.

[9]  C. Marth,et al.  Modulation of tumour marker CA-125 expression in cultured ovarian carcinoma cells. , 1992, European journal of cancer.

[10]  R. Elashoff,et al.  Multiple markers for lung cancer diagnosis: validation of models for localized lung cancer. , 1988, Journal of the National Cancer Institute.

[11]  C. Mountain.  The new International Staging System for Lung Cancer. , 1986, The Surgical clinics of North America.

[12]  D. Carney.  Lung cancer biology. , 1991, Current opinion in oncology.

[13]  J. Balibrea,et al.  Evaluation of serum ca 125 as a tumor marker in non‐small cell lung cancer , 1991, Cancer.

[14]  K. Hamamoto,et al.  Serum CA125 level is a good prognostic indicator in lung cancer. , 1990, British Journal of Cancer.

[15]  R. Bast,et al.  The CA 125 tumour-associated antigen: a review of the literature. , 1989, Human reproduction.

[16]  D. Ferrigno,et al.  Prognostic value of the tissue polypeptide antigen in lung cancer. , 1992, Chest.

[17]  Y. Mizushima,et al.  Clinical significance of the number of positive tumor markers in assisting the diagnosis of lung cancer with multiple tumor marker assay. , 1990, Oncology.

[18]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .

[19]  J A TAIANA,et al.  [Cancer of the lung]. , 1952, The Journal of the International College of Surgeons.

[20]  A. Gazdar,et al.  The pathology of lung cancer--changing concepts and newer diagnostic techniques. , 1988, Seminars in oncology.

[21]  H. Dosaka-akita,et al.  Prognostic significance of the expression of ras oncogene product in non‐small cell lung cancer , 1992, Cancer.